•

    • [ CAS No. 2189684-44-2 ] Lenacapavir

    Noatic, our company, is a leading supplier of pharmaceutical in China, with a history dating back to 2015. We offer CMO/CRO service and prioritize delivering high-quality products in a timely manner. Join us as our partner today!

    Product Name: Lenacapavir

    CAS: 2189684-44-2

    MF: C39H32ClF10N7O5S2

    MW: 968.28

    Apprearance: Off-white powder

    Purity：99%min

    Package: PE bag

    MOQ: 1g

    Storage : well sealed in RM temperature  

    Classification: NON-DG

    Shelf life: Two years

    Availability: Yes

    Application:  intermediates of Lenacapavir , used to treat HIV 

    ※ Products under patent protection are only for R&D purposes.

    Product Description

    Lenacapavir [CAS No. 2189684-44-2] is a revolutionary pharmaceutical intermediate product from our manufacturing plant, designed to offer remarkable results to those seeking effective antimicrobial agents. As a highly potent HIV-1 capsid inhibitor, Lenacapavir [CAS No. 2189684-44-2] presents versatile applications and functions that make it one of the most desirable products in the market. With its exceptional efficacy against viral strains, low toxicity, and optimal pharmacokinetic properties, Lenacapavir [CAS No. 2189684-44-2] guarantees unparalleled results that meet industry standards. Order your Lenacapavir [CAS No. 2189684-44-2] product today and rest assured that you are getting high-quality and reliable pharmaceutical intermediates that provide the best value for your money.

    Product Features

    • CAS No. 2189684-44-2 - unique identifier for easy tracking and reference
    • Lenacapavir - product name for easy identification
    • High purity - ensures quality and effectiveness
    • Suitable for research and development of HIV/AIDS treatment - potential implications for medical advancements

    Application of 2189684-44-2

    • Lenacapavir is a novel HIV-1 capsid inhibitor.
    • It has been developed as a potential therapy for people living with HIV-1 who have developed resistance to existing therapies.
    • Lenacapavir has demonstrated good tolerability and has the potential to be a long-acting, injectable therapy for HIV-1.
    • It has shown promising results in reducing viral load in clinical trials.
    • Lenacapavir is intended for use in combination with other antiretroviral medications for the treatment of HIV-1.

    Package and shipping

    Usually, we sell products with original packages but also be instructed by the customer

    Transportation: instructed by the customer. Please contact us for shipping details

    We Provide Data Analytics Techniques & Solutions

    1. Are you manufacturer?

    Yes, We are manufacturer and our own factory locates in provincial chemical park,you are welcome any time to visit our plant.

    3. What 's your sample policy?

    In order to support the develop of the new project , we can provide free sample for some items and you should bear the shipping cost.

    2. What is the lead time?

    Usually we will prepare some stock for hot sale items, if no stock ,we will arrange prompt production and lead time will take 2-4 weeks.

    Send Inquiry